BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31705243)

  • 1. Catheter-Directed Computed Tomography Hepatic Angiography for Yttrium-90 Selective Internal Radiotherapy of Hepatocellular Carcinoma Reduces Prophylactic Embolization of Extrahepatic Vessels.
    Goh WXT; Leong S; Too CW; Cheng LT; Saffari SE; Lee RZ; Ng STS; Lo RHG; Tay KH; Chan SXJM; Gogna A; Irani FG; Venkatanarasimha N; Loke KSH; Chow PKH; Ng DCE; Urlings TAJ; Patel A; Damodharan K; Toh LHW; Tan BS
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):478-487. PubMed ID: 31705243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?
    Theysohn JM; Ruhlmann M; Müller S; Dechene A; Best J; Haubold J; Umutlu L; Gerken G; Bockisch A; Lauenstein TC
    PLoS One; 2015; 10(9):e0137587. PubMed ID: 26335790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomography hepatic arteriography has a hepatic falciform artery detection rate that is much higher than that of digital subtraction angiography and 99mTc-MAA SPECT/CT: implications for planning 90Y radioembolization?
    Burgmans MC; Too CW; Kao YH; Goh AS; Chow PK; Tan BS; Tay KH; Lo RH
    Eur J Radiol; 2012 Dec; 81(12):3979-84. PubMed ID: 22954411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
    Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
    J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization.
    Heusner TA; Hamami ME; Ertle J; Hahn S; Poeppel T; Hilgard P; Bockisch A; Forsting M; Antoch G
    Rofo; 2010 Jul; 182(7):603-8. PubMed ID: 20183775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.
    Lau WY; Kennedy AS; Kim YH; Lai HK; Lee RC; Leung TW; Liu CS; Salem R; Sangro B; Shuter B; Wang SC
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):401-7. PubMed ID: 20950954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective internal radiotherapy (SIRT) of hepatic tumors: how to deal with the cystic artery.
    Theysohn JM; Müller S; Schlaak JF; Ertle J; Schlosser TW; Bockisch A; Lauenstein TC
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1015-22. PubMed ID: 22983697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of new hepaticoenteric collateral pathways after hepatic arterial skeletonization in preparation for yttrium-90 radioembolization.
    Abdelmaksoud MH; Hwang GL; Louie JD; Kothary N; Hofmann LV; Kuo WT; Hovsepian DM; Sze DY
    J Vasc Interv Radiol; 2010 Sep; 21(9):1385-95. PubMed ID: 20688531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in hepatic hemodynamics assessed by hepatic arterial blood pressure and computed tomography during hepatic angiography with the double balloon technique.
    Inoue A; Ota S; Takaki K; Imai Y; Sato S; Watanabe S; Tomozawa Y; Iwai T; Murakami Y; Sonoda A; Nitta N; Murata K
    Jpn J Radiol; 2019 Jun; 37(6):487-493. PubMed ID: 30927199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
    Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A
    Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization.
    Louie JD; Kothary N; Kuo WT; Hwang GL; Hofmann LV; Goris ML; Iagaru AH; Sze DY
    J Vasc Interv Radiol; 2009 May; 20(5):606-13. PubMed ID: 19345589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in Imaging Findings on Angiography-Assisted CT During Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
    Yoshimatsu R; Yamagami T; Ishikawa M; Kajiwara K; Aikata H; Chayama K; Awai K
    Cardiovasc Intervent Radiol; 2016 Jun; 39(6):865-74. PubMed ID: 26711803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
    Wang EA; Stein JP; Bellavia RJ; Broadwell SR
    Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of Yttrium-90 Radioembolization Dose Calculation Utilizing Intra-procedural Open Trajectory Cone Beam CT.
    O'Connor PJ; Pasik SD; van der Bom IM; Bishay V; Radaelli A; Kim E
    Cardiovasc Intervent Radiol; 2020 Feb; 43(2):295-301. PubMed ID: 31578635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrahepatic Arteries Originating from Hepatic Arteries: Analysis Using CT During Hepatic Arteriography and Visualization on Digital Subtraction Angiography.
    Ozaki K; Kobayashi S; Matsui O; Minami T; Koda W; Gabata T
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):822-830. PubMed ID: 28083645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective analysis of selective internal radiation therapy (SIRT) with yttrium-90 microspheres in patients with unresectable hepatic malignancies.
    Omed A; Lawrance JA; Murphy G; Laasch HU; Wilson G; Illidge T; Tipping J; Zivanovic M; Jeans S
    Clin Radiol; 2010 Sep; 65(9):720-8. PubMed ID: 20696299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
    Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
    Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.
    Kao YH; Hock Tan AE; Burgmans MC; Irani FG; Khoo LS; Gong Lo RH; Tay KH; Tan BS; Hoe Chow PK; Eng Ng DC; Whatt Goh AS
    J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors.
    Pöpperl G; Helmberger T; Münzing W; Schmid R; Jacobs TF; Tatsch K
    Cancer Biother Radiopharm; 2005 Apr; 20(2):200-8. PubMed ID: 15869456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.